2025-02-23T03:42:43-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: Query fl=%2A&wt=json&json.nl=arrarr&q=id%3A%22irk-123456789-134932%22&qt=morelikethis&rows=5
2025-02-23T03:42:43-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: => GET http://localhost:8983/solr/biblio/select?fl=%2A&wt=json&json.nl=arrarr&q=id%3A%22irk-123456789-134932%22&qt=morelikethis&rows=5
2025-02-23T03:42:43-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: <= 200 OK
2025-02-23T03:42:43-05:00 DEBUG: Deserialized SOLR response
Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR

Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR

Aim: To determine and compare cytokeratin 20 (CK20) mRNA expression in urine of patients with transitional cell carcinomas of bladder (TCCB), urological benign diseases, and healthy volunteers. Methods: Taqman probe was designed according to the sequence of CK20 cloned gene. The quantitative PCR r...

Full description

Saved in:
Bibliographic Details
Main Authors: Guo, B., Luo, C., Xun, C., Xie, J., Wu, X., Pu, J.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2009
Series:Experimental Oncology
Subjects:
Original contributions
Online Access:http://dspace.nbuv.gov.ua/handle/123456789/134932
Tags: Add Tag
No Tags, Be the first to tag this record!
id irk-123456789-134932
record_format dspace
spelling irk-123456789-1349322018-06-15T03:06:23Z Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR Guo, B. Luo, C. Xun, C. Xie, J. Wu, X. Pu, J. Original contributions Aim: To determine and compare cytokeratin 20 (CK20) mRNA expression in urine of patients with transitional cell carcinomas of bladder (TCCB), urological benign diseases, and healthy volunteers. Methods: Taqman probe was designed according to the sequence of CK20 cloned gene. The quantitative PCR reaction system was optimized and evaluated. The CK20 mRNA level was screened by real-time polymerase chain reaction (RT-PCR) in 95 urine samples and analyzed according to the following parameters: urinary cytology, nuclear matrix protein 22 (NMP22) expression, tumor stage and grade. Results: For 60 TCCB patients urinary cytology was positive in 28 (46.7%), control group had no false-positive results (specificity 100%). CK20 expression was positive in RT-PCR of 51 cases (85%) of TCCB, but control group was positive in 2 cases (specificity 94.3%) with a cutoff value of crossover point (CT) = 30. Two methods have significant variation in sensitivity (p < 0.001), NMP22 expression was positive in 47 cases (78.3%), but control group was positive in 9 cases (specificity 85%). In the simultaneous evaluation of CK20 and NMP22 mRNA expression, there were 54 positive cases (90%). CK20 mRNA values in TCCB group (mean 27712.57 copies/µl) were significantly higher than in non-cancer disease urological group (mean 74.45 copies/µl) and control group (mean 8.47 copies/µl) (p < 0.001, p < 0.001, respectively). CK20 mRNA values increased gradually with higher tumor grade and stage: G1 differs significantly from G2 (p = 0.016); Tis/Ta differs significantly from T1–2 (p = 0.022). Conclusion: Our results indicate that CK20 mRNA expression could be regarded as a potential marker for TCCB. We demonstrated correlation between CK20 expression and the clinicopathologic features of TCCB (tumor stage and grade); simultaneous use of CK20 and NMP22 markers will elevate the sensitivity of the method. CK20 RT-PCR is a sensitive, quantitative, rapid and specific method to detect free cancer cells in the urine, and could be recommended for be wide application in the diagnostics of TCCB and evaluation of therapeutic effect. 2009 Article Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR / B. Guo1, C. Luo, C. Xun, J. Xie, X. Wu, J. Pu // Experimental Oncology. — 2009. — Т. 31, № 1. — С. 43-47. — Бібліогр.: 21 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/134932 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
language English
topic Original contributions
Original contributions
spellingShingle Original contributions
Original contributions
Guo, B.
Luo, C.
Xun, C.
Xie, J.
Wu, X.
Pu, J.
Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR
Experimental Oncology
description Aim: To determine and compare cytokeratin 20 (CK20) mRNA expression in urine of patients with transitional cell carcinomas of bladder (TCCB), urological benign diseases, and healthy volunteers. Methods: Taqman probe was designed according to the sequence of CK20 cloned gene. The quantitative PCR reaction system was optimized and evaluated. The CK20 mRNA level was screened by real-time polymerase chain reaction (RT-PCR) in 95 urine samples and analyzed according to the following parameters: urinary cytology, nuclear matrix protein 22 (NMP22) expression, tumor stage and grade. Results: For 60 TCCB patients urinary cytology was positive in 28 (46.7%), control group had no false-positive results (specificity 100%). CK20 expression was positive in RT-PCR of 51 cases (85%) of TCCB, but control group was positive in 2 cases (specificity 94.3%) with a cutoff value of crossover point (CT) = 30. Two methods have significant variation in sensitivity (p < 0.001), NMP22 expression was positive in 47 cases (78.3%), but control group was positive in 9 cases (specificity 85%). In the simultaneous evaluation of CK20 and NMP22 mRNA expression, there were 54 positive cases (90%). CK20 mRNA values in TCCB group (mean 27712.57 copies/µl) were significantly higher than in non-cancer disease urological group (mean 74.45 copies/µl) and control group (mean 8.47 copies/µl) (p < 0.001, p < 0.001, respectively). CK20 mRNA values increased gradually with higher tumor grade and stage: G1 differs significantly from G2 (p = 0.016); Tis/Ta differs significantly from T1–2 (p = 0.022). Conclusion: Our results indicate that CK20 mRNA expression could be regarded as a potential marker for TCCB. We demonstrated correlation between CK20 expression and the clinicopathologic features of TCCB (tumor stage and grade); simultaneous use of CK20 and NMP22 markers will elevate the sensitivity of the method. CK20 RT-PCR is a sensitive, quantitative, rapid and specific method to detect free cancer cells in the urine, and could be recommended for be wide application in the diagnostics of TCCB and evaluation of therapeutic effect.
format Article
author Guo, B.
Luo, C.
Xun, C.
Xie, J.
Wu, X.
Pu, J.
author_facet Guo, B.
Luo, C.
Xun, C.
Xie, J.
Wu, X.
Pu, J.
author_sort Guo, B.
title Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR
title_short Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR
title_full Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR
title_fullStr Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR
title_full_unstemmed Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR
title_sort quantitative detection of cytokeratin 20 mrna in urine samples as diagnostic tools for bladder cancer by real-time pcr
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
publishDate 2009
topic_facet Original contributions
url http://dspace.nbuv.gov.ua/handle/123456789/134932
citation_txt Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR / B. Guo1, C. Luo, C. Xun, J. Xie, X. Wu, J. Pu // Experimental Oncology. — 2009. — Т. 31, № 1. — С. 43-47. — Бібліогр.: 21 назв. — англ.
series Experimental Oncology
work_keys_str_mv AT guob quantitativedetectionofcytokeratin20mrnainurinesamplesasdiagnostictoolsforbladdercancerbyrealtimepcr
AT luoc quantitativedetectionofcytokeratin20mrnainurinesamplesasdiagnostictoolsforbladdercancerbyrealtimepcr
AT xunc quantitativedetectionofcytokeratin20mrnainurinesamplesasdiagnostictoolsforbladdercancerbyrealtimepcr
AT xiej quantitativedetectionofcytokeratin20mrnainurinesamplesasdiagnostictoolsforbladdercancerbyrealtimepcr
AT wux quantitativedetectionofcytokeratin20mrnainurinesamplesasdiagnostictoolsforbladdercancerbyrealtimepcr
AT puj quantitativedetectionofcytokeratin20mrnainurinesamplesasdiagnostictoolsforbladdercancerbyrealtimepcr
first_indexed 2023-10-18T21:10:32Z
last_indexed 2023-10-18T21:10:32Z
_version_ 1796152117155594240

Similar Items